Developer docs
API playgroundTry for free, no card

Search company profiles

GreenCare Pharma

Full company profile

uuid000rkhd

Namestring
GreenCare Pharma
Legal namestring
GreenCare
Websiteurl
greencare.store
Company typeenum
Private
Founded yearint
2018
Descriptiontext

GreenCare Pharma is a privately-held Brazilian pharmaceutical company that imports and distributes cannabinoid-based medications under its proprietary Hempflex brand to patients holding valid medical prescriptions. The company operates exclusively in the Brazilian market and facilitates the end-to-end workflow from physician prescription through ANVISA (Brazilian Health Regulatory Agency) authorization to product delivery, positioning itself as the "fastest-growing company in Brazil's cannabinoid-based medication segment" per its own corporate materials.

The company's core offering is the Hempflex product line of CBD and THC formulations manufactured according to international regulatory standards, imported into Brazil and sold via an e-commerce store, phone sales, WhatsApp, and direct customer support. It operates a B2B2C model targeting two primary segments: licensed physicians (recruited and educated through the Instituto GreenCare e-learning platform) and patients (guided through documentation, ANVISA filing, and importation logistics). Technology infrastructure is centered on a WordPress storefront, a dedicated physician portal, and the PATIENTCARE patient portal at patient.greencarepharma.com.br.

GreenCare monetizes through one-time cannabis medication sales and bundled patient support services that handle ANVISA bureaucratic procedures and delivery coordination. Pricing is not publicly disclosed and requires direct contact. The company's differentiation rests on three pillars: medical education via Instituto GreenCare, strategic global partnerships providing exclusive access to internationally recognized quality products, and full-service regulatory facilitation. Key data gaps include the absence of disclosed revenue, headcount, funding history, ownership structure, and management team information.

Short descriptiontext

GreenCare Pharma is a privately-held Brazilian pharmaceutical company that imports and distributes Hempflex-branded cannabinoid-based medications (CBD and THC formulations) to patients with valid prescriptions, supporting physicians via its Instituto GreenCare e-learning platform and handling ANVISA regulatory facilitation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Keyword5 values
medical cannabis products, cannabinoid medications, pharmaceutical importation, patient support services, medical education platform
Industry3 codes
PRIMARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAGAG
Medical Cannabis Delivery & Online Ordering
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
SECONDARYCRANAGAE
Dispensary-Owned Online Ordering & Delivery (Direct-to-Consumer)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Pharmacies and Drug Retailers456110
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Medical Cannabis Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cannabis Medication Sales
TypeOne Time License
Description

GreenCare imports and sells cannabis-based medications (Hempflex brand) to patients with valid medical prescriptions in Brazil. The company facilitates the entire process including ANVISA documentation, authorization handling, and product delivery.

greencare.store
2Patient Support Services
TypeProfessional Services
Description

The company assists patients throughout the purchase and importation process, handling bureaucratic procedures with ANVISA, providing medical information support, and managing product delivery logistics.

greencare.store
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Hempflex
Description

Product brand line for cannabinoid-based medications, manufactured according to global regulatory practices, offering legally compliant, safe, and effective products derived from cannabinoids.

greencare.store
Core offering1 text field

GreenCare imports and sells cannabis-based pharmaceutical products under the Hempflex brand to patients in Brazil who hold a valid medical prescription. The company manages the full process — prescription intake, ANVISA documentation and authorization, importation logistics, and home delivery — and supports prescribing physicians with scientific information, technical assistance, and continuing medical education through the Instituto GreenCare (IGC) e-learning platform.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

GreenCare Pharma is a Brazilian pharmaceutical company specializing in medical cannabis products. The company operates primarily through its Hempflex product line, which comprises cannabinoid-based medications (CBD and THC formulations) imported into Brazil and distributed to patients with valid medical prescriptions. GreenCare facilitates the entire import process, including ANVISA authorization handling and direct delivery to patients. The company also provides educational resources for physicians through the Instituto GreenCare (IGC) e-learning platform and maintains a compliance hotline for ethical reporting.

Product and service3 records
1Hempflex
CategoryMedical cannabis pharmaceuticals
Description

GreenCare's main product line of cannabinoid-based medicines, including CBD and THC formulations, manufactured according to international regulatory standards and imported into Brazil for patients with valid medical prescriptions.

2Instituto GreenCare (IGC)
CategoryMedical education and training
Description

E-learning platform delivering continuing medical education on cannabinoid-based therapeutics to licensed healthcare professionals, who share knowledge and clinical experience with Hempflex products.

3PATIENTCARE
CategoryPatient support services
Description

Patient portal (patient.greencarepharma.com.br) where patients in Brazil submit required documentation, manage their accounts, and access ongoing support for their cannabis-based treatment under GreenCare.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Instituto GreenCare (IGC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Instituto GreenCare is the company's proprietary e-learning platform for continuing medical education in cannabinoid-based therapeutics. Healthcare professionals share knowledge and experiences about cannabinoid products through this platform, serving as the company's primary educational and GTM mechanism for the physician segment.

greencare.store
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Sativaria Brasil
TypeDirect peer
Description

Brazilian medical cannabis company importing and distributing cannabinoid products to patients with prescriptions. Comparable in regulatory pathway focus, product importation, and patient services.

TypeEmerging player
Description

Cannabinoid-based pharmaceutical company developing prescription products for therapeutic indications. Comparable in the pharmaceutical-grade cannabis medication positioning and clinical/regulatory focus.

TypeBroad incumbent
Description

Global cannabis producer with medical cannabis portfolios across multiple jurisdictions. Adjacent incumbent with potential to compete in Brazil through institutional partnerships and product breadth.

TypeEmerging player
Description

Cannabis company with Latin American focus including physician education and patient services. Comparable in the B2B2C medical cannabis model targeted at Latin American physicians and patients.

5Mantecorp Farmasa (cannabis line)
TypeBroad incumbent
Description

Established Brazilian pharmaceutical company that has expanded into medical cannabis products. Comparable on the pharmaceutical-grade medications positioning, but with a broader pharma portfolio and distribution scale.

TypeDirect peer
Description

Brazilian medical cannabis patient association that cultivates, manufactures, and distributes cannabis-based medications to patients with medical prescriptions. Directly comparable in B2B2C physician-and-patient model, ANVIA pathway navigation, and Brazilian market focus.

7OnixCann
TypeDirect peer
Description

Brazilian medical cannabis operator focused on patient access to imported cannabis-based medications under ANVIA. Direct competitor in the same regulatory pathway and physician-engagement model.

TypeEmerging player
Description

International medical cannabis cultivator and manufacturer with export capabilities into emerging regulated markets including Latin America. Comparable as a potential upstream supplier/partner for GreenCare's imported product line.

9Tilray Brands
TypeBroad incumbent
Description

Large international cannabis producer with established operations in Brazil and globally. Broad incumbent providing similar cannabis-based medications internationally, with significant scale advantages in cultivation and capital.

TypeDirect peer
Description

Brazilian medical cannabis operator supporting patients through the ANVIA authorization and importation process with a similar prescriber-enablement model. Overlaps directly with GreenCare on the service-stack and importation facilitation positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GreenCare Pharma

Medical Cannabis Pharmaceuticalsgreencare.store

GreenCare Pharma is a privately-held Brazilian pharmaceutical company that imports and distributes Hempflex-branded cannabinoid-based medications (CBD and THC formulations) to patients with valid prescriptions, supporting physicians via its Instituto GreenCare e-learning platform and handling ANVISA regulatory facilitation.

What GreenCare Pharma does

GreenCare Pharma is a privately-held Brazilian pharmaceutical company that imports and distributes cannabinoid-based medications under its proprietary Hempflex brand to patients holding valid medical prescriptions. The company operates exclusively in the Brazilian market and facilitates the end-to-end workflow from physician prescription through ANVISA (Brazilian Health Regulatory Agency) authorization to product delivery, positioning itself as the "fastest-growing company in Brazil's cannabinoid-based medication segment" per its own corporate materials.

The company's core offering is the Hempflex product line of CBD and THC formulations manufactured according to international regulatory standards, imported into Brazil and sold via an e-commerce store, phone sales, WhatsApp, and direct customer support. It operates a B2B2C model targeting two primary segments: licensed physicians (recruited and educated through the Instituto GreenCare e-learning platform) and patients (guided through documentation, ANVISA filing, and importation logistics). Technology infrastructure is centered on a WordPress storefront, a dedicated physician portal, and the PATIENTCARE patient portal at patient.greencarepharma.com.br.

GreenCare monetizes through one-time cannabis medication sales and bundled patient support services that handle ANVISA bureaucratic procedures and delivery coordination. Pricing is not publicly disclosed and requires direct contact. The company's differentiation rests on three pillars: medical education via Instituto GreenCare, strategic global partnerships providing exclusive access to internationally recognized quality products, and full-service regulatory facilitation. Key data gaps include the absence of disclosed revenue, headcount, funding history, ownership structure, and management team information.

GreenCare Pharma firmographics

Firmographics
Name
GreenCare Pharma
Legal name
GreenCare
Website
https://greencare.store
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
101–250 employees
Short description
GreenCare Pharma is a privately-held Brazilian pharmaceutical company that imports and distributes Hempflex-branded cannabinoid-based medications (CBD and THC formulations) to patients with valid prescriptions, supporting physicians via its Instituto GreenCare e-learning platform and handling ANVISA regulatory facilitation.
Ownership category
akta.pro rank

GreenCare Pharma industry classification

Industry
Product category
Medical Cannabis Pharmaceuticals
NAICS
Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmacies and Drug Retailers (456110)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAGAG
Medical Cannabis Delivery & Online Ordering
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
SECONDARYCRANAGAE
Dispensary-Owned Online Ordering & Delivery (Direct-to-Consumer)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail

Keywords

  • Medical cannabis products
  • Cannabinoid medications
  • Pharmaceutical importation
  • Patient support services
  • Medical education platform

Where GreenCare Pharma is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Markets served

GreenCare Pharma business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Cannabis Medication Sales: GreenCare imports and sells cannabis-based medications (Hempflex brand) to patients with valid medical prescriptions in Brazil. The company facilitates the entire process including ANVISA documentation, authorization handling, and product delivery.
  2. Patient Support Services: The company assists patients throughout the purchase and importation process, handling bureaucratic procedures with ANVISA, providing medical information support, and managing product delivery logistics.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

GreenCare Pharma product offering

Product offering

Core offering

GreenCare imports and sells cannabis-based pharmaceutical products under the Hempflex brand to patients in Brazil who hold a valid medical prescription. The company manages the full process — prescription intake, ANVISA documentation and authorization, importation logistics, and home delivery — and supports prescribing physicians with scientific information, technical assistance, and continuing medical education through the Instituto GreenCare (IGC) e-learning platform.

Product overview

GreenCare Pharma is a Brazilian pharmaceutical company specializing in medical cannabis products. The company operates primarily through its Hempflex product line, which comprises cannabinoid-based medications (CBD and THC formulations) imported into Brazil and distributed to patients with valid medical prescriptions. GreenCare facilitates the entire import process, including ANVISA authorization handling and direct delivery to patients. The company also provides educational resources for physicians through the Instituto GreenCare (IGC) e-learning platform and maintains a compliance hotline for ethical reporting.

Differentiator

Problem solved

Functional benefit

Brands

  • Hempflex: Product brand line for cannabinoid-based medications, manufactured according to global regulatory practices, offering legally compliant, safe, and effective products derived from cannabinoids.

Products and services

  • Hempflex GreenCare's main product line of cannabinoid-based medicines, including CBD and THC formulations, manufactured according to international regulatory standards and imported into Brazil for patients with valid medical prescriptions.
  • Instituto GreenCare (IGC) E-learning platform delivering continuing medical education on cannabinoid-based therapeutics to licensed healthcare professionals, who share knowledge and clinical experience with Hempflex products.
  • PATIENTCARE Patient portal (patient.greencarepharma.com.br) where patients in Brazil submit required documentation, manage their accounts, and access ongoing support for their cannabis-based treatment under GreenCare.

Companies that use GreenCare Pharma

Customer profile

Segments2 records

Ideal customer profiles2 records

GreenCare Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

GreenCare Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Instituto GreenCare (IGC)coreStrategic or Co-development PartnerInstituto GreenCare is the company's proprietary e-learning platform for continuing medical education in cannabinoid-based therapeutics. Healthcare professionals share knowledge and experiences about cannabinoid products through this platform, serving as the company's primary educational and GTM mechanism for the physician segment.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

GreenCare Pharma competitors and assessment

Company assessment

Direct peers

  • Sativaria Brasil: Brazilian medical cannabis company importing and distributing cannabinoid products to patients with prescriptions. Comparable in regulatory pathway focus, product importation, and patient services.
  • Abrace Vida (formerly Abrace Esperança): Brazilian medical cannabis patient association that cultivates, manufactures, and distributes cannabis-based medications to patients with medical prescriptions. Directly comparable in B2B2C physician-and-patient model, ANVIA pathway navigation, and Brazilian market focus.
  • OnixCann: Brazilian medical cannabis operator focused on patient access to imported cannabis-based medications under ANVIA. Direct competitor in the same regulatory pathway and physician-engagement model.
  • Cannect: Brazilian medical cannabis operator supporting patients through the ANVIA authorization and importation process with a similar prescriber-enablement model. Overlaps directly with GreenCare on the service-stack and importation facilitation positioning.

Emerging players

  • Zelira Therapeutics: Cannabinoid-based pharmaceutical company developing prescription products for therapeutic indications. Comparable in the pharmaceutical-grade cannabis medication positioning and clinical/regulatory focus.
  • Khiron Life Sciences: Cannabis company with Latin American focus including physician education and patient services. Comparable in the B2B2C medical cannabis model targeted at Latin American physicians and patients.
  • Clever Leaves: International medical cannabis cultivator and manufacturer with export capabilities into emerging regulated markets including Latin America. Comparable as a potential upstream supplier/partner for GreenCare's imported product line.

Broad incumbents

  • Canopy Growth Corporation: Global cannabis producer with medical cannabis portfolios across multiple jurisdictions. Adjacent incumbent with potential to compete in Brazil through institutional partnerships and product breadth.
  • Mantecorp Farmasa (cannabis line): Established Brazilian pharmaceutical company that has expanded into medical cannabis products. Comparable on the pharmaceutical-grade medications positioning, but with a broader pharma portfolio and distribution scale.
  • Tilray Brands: Large international cannabis producer with established operations in Brazil and globally. Broad incumbent providing similar cannabis-based medications internationally, with significant scale advantages in cultivation and capital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

GreenCare Pharma social profiles

Digital presence

GreenCare Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GreenCare Pharma leadership team

Management profile

Number of profiles

GreenCare Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GreenCare Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GreenCare Pharma

What does GreenCare Pharma do?

GreenCare imports and sells cannabis-based pharmaceutical products under the Hempflex brand to patients in Brazil who hold a valid medical prescription. The company manages the full process — prescription intake, ANVISA documentation and authorization, importation logistics, and home delivery — and supports prescribing physicians with scientific information, technical assistance, and continuing medical education through the Instituto GreenCare (IGC) e-learning platform.

Is GreenCare Pharma a public or private company?

GreenCare Pharma is a private company. It is classified as unknown and is currently operating.

When was GreenCare Pharma founded?

GreenCare Pharma was founded in 2018. It employs 101 to 250 people.

Where is GreenCare Pharma based?

GreenCare Pharma is headquartered in São Paulo, Brazil, in the Latin America region.

How does GreenCare Pharma make money?

Two revenue lines are on record. Cannabis Medication Sales are the primary driver. The others are patient Support Services.

Who are GreenCare Pharma's main competitors?

Direct peers on record are Sativaria Brasil, Abrace Vida (formerly Abrace Esperança), OnixCann and Cannect. Emerging players are Zelira Therapeutics, Khiron Life Sciences and Clever Leaves. Broad incumbents are Canopy Growth Corporation, Mantecorp Farmasa (cannabis line) and Tilray Brands.

Does GreenCare Pharma have an API?

No public API is recorded for GreenCare Pharma.

What industry is GreenCare Pharma in?

GreenCare Pharma's product category is Medical Cannabis Pharmaceuticals. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAGAG, Medical Cannabis Delivery & Online Ordering. Its NAICS code is 325411 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals